Badreddin Edris sold $3.4M of Edgewise Therapeutics (EWTX)

Executed Jan 21, disclosed Jan 23, 2 days later.

Value, as filed

$3.4M

115,471 sh across 5 lots

Executed

Jan 21

the trade date, as filed

Disclosed

Jan 23

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BE Badreddin Edris Director profile →

Badreddin Edris (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in SWTX. The largest single filing was $3.4M of EWTX (115,471 sh across 5 lots, as filed), executed Jan 21.

The name

EWTX

Edgewise Therapeutics, Inc. EWTX · Healthcare · 28 filings in 24 months ticker →

Healthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→